How did Bayer AG's revenue change from 2024 to 2025?

Bayer AG reported $49.5B in revenue for fiscal year 2025. This represents a -2.6% change compared to 2024. Sales eased about 2.6% to $49.5 billion in 2025 amid continued Xarelto generic erosion and glyphosate weakness, even as corn seed impairment reversals lifted reported earnings.

FY2025 Revenue

$49.5B

▼ 2.6% vs FY2024 ($50.8B)

Source: Annual report / company filing

Bayer AG reported $49.5B in revenue for fiscal year 2025. This represents a decline of 2.6% compared to the 2024 figure of $50.8B.

Sales eased about 2.6% to $49.5 billion in 2025 amid continued Xarelto generic erosion and glyphosate weakness, even as corn seed impairment reversals lifted reported earnings.

Revenue by Year

FY2025 FY2024 FY2023 FY2022

Bayer AG Annual Revenue History

Year	Revenue	YoY Change
FY2025	$49.5B	-2.6%
FY2024	$50.8B	-2.1%
FY2023	$51.9B	+2.4%
FY2022	$50.7B	—

Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.

← Previous year

FY2024: $50.8B

Explore Bayer AG

Core profile pages, annual revenue records, and related research hubs for this company.